These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12551836)

  • 1. Expressions of vascular endothelial growth factor and angiopoietin-2 in myeloma cells.
    Uneda S; Matsuno F; Sonoki T; Tniguchi I; Kawano F; Hata H
    Haematologica; 2003 Jan; 88(1):113-5. PubMed ID: 12551836
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma.
    Mitsuhashi N; Shimizu H; Ohtsuka M; Wakabayashi Y; Ito H; Kimura F; Yoshidome H; Kato A; Nukui Y; Miyazaki M
    Hepatology; 2003 May; 37(5):1105-13. PubMed ID: 12717391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietins, growth factors, and vascular morphology in early arthritis.
    Fearon U; Griosios K; Fraser A; Reece R; Emery P; Jones PF; Veale DJ
    J Rheumatol; 2003 Feb; 30(2):260-8. PubMed ID: 12563678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Doussis-Anagnostopoulou et al. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease. J Pathol 2002; 197: 677-683.
    Agarwal B; Naresh KN
    J Pathol; 2003 Oct; 201(2):334-5. PubMed ID: 14517852
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical investigation of VEGF expression in lung cancer--a possible diagnostic tool in micrometastasis].
    Ohta Y; Oda M; Watanabe G
    Nihon Rinsho; 2002 May; 60 Suppl 5():743-7. PubMed ID: 12101776
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of vascular endothelial growth factor/ vascular permeability factor in periapical lesions.
    Leonardi R; Caltabiano M; Pagano M; Pezzuto V; Loreto C; Palestro G
    J Endod; 2003 Mar; 29(3):180-3. PubMed ID: 12669876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical implications of angiogenesis in the treatment of cancer.
    Aoun E; Taher A
    J Med Liban; 2002; 50(1-2):32-8. PubMed ID: 12841311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiogenic inducers and inhibitors].
    Shukunami C; Hiraki Y
    Tanpakushitsu Kakusan Koso; 2000 Sep; 45(13 Suppl):2131-8. PubMed ID: 11021214
    [No Abstract]   [Full Text] [Related]  

  • 10. [Induction of angiogenesis in ischemic myocardium by adenovirus mediated angiopoietin-1 gene transfer, an experimental study].
    Chen SL; Zhang BR; Mei J; Xu ZY; Zhu JL; Cai KH; Huang SD; Liu YL
    Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):637-40. PubMed ID: 12887817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow angiogenesis in multiple myeloma: closing in on the loop.
    Molina JR; Rajkumar SV
    Haematologica; 2003 Feb; 88(2):122-4. PubMed ID: 12604399
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
    Keyes KA; Mann L; Cox K; Treadway P; Iversen P; Chen YF; Teicher BA
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):321-7. PubMed ID: 12721760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between epidermal growth factor and overexpression of vascular endothelial growth factor in hepatocellular carcinoma].
    Huang G; Yang L; Yang J; Liu H; Yang Z
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):564-6. PubMed ID: 12667326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and significance of the vascular permeability factor in nasal polyps.
    Yang J; Dong Z; Kong H; Guan G; Yang Z
    Chin Med J (Engl); 2002 Aug; 115(8):1251-2. PubMed ID: 12515274
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical significance of biological prognostic factors in non-Hodgkin lymphoma: analysis of serum and cell surface nm 23-H1 protein].
    Niitsu N
    Rinsho Ketsueki; 2003 Apr; 44(4):211-8. PubMed ID: 12784653
    [No Abstract]   [Full Text] [Related]  

  • 16. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis.
    Giuliani N; Colla S; Lazzaretti M; Sala R; Roti G; Mancini C; Bonomini S; Lunghi P; Hojden M; Genestreti G; Svaldi M; Coser P; Fattori PP; Sammarelli G; Gazzola GC; Bataille R; Almici C; Caramatti C; Mangoni L; Rizzoli V
    Blood; 2003 Jul; 102(2):638-45. PubMed ID: 12649156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum.
    Al-zi'abi MO; Watson ED; Fraser HM
    Reproduction; 2003 Feb; 125(2):259-70. PubMed ID: 12578540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-1 and pulmonary hypertension: cause or cure?
    Rudge JS; Thurston G; Yancopoulos GD
    Circ Res; 2003 May; 92(9):947-9. PubMed ID: 12750304
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular control of physiological skin angiogenesis.
    Odorisio T; Failla CM; Zambruno G
    Eur J Dermatol; 2002; 12(6):VII-X. PubMed ID: 12506892
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
    Olaso E; Vidal-Vanaclocha F
    Methods Mol Med; 2003; 85():79-86. PubMed ID: 12710199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.